From Protein Or Biologically Active Polypeptide Containing Monomer Patents (Class 526/238.1)
-
Patent number: 11827747Abstract: The present invention concerns a polymer comprising repetitive units having the following formula (I) wherein R1 is H or Me; L is a linker; R2 is the side chain of an ?-amino acid being other than arginine; m is 0 or an integer comprised from 1 to 10; n is an integer comprised from 1 to 10; and X— is a counterion.Type: GrantFiled: May 6, 2020Date of Patent: November 28, 2023Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM), UNIVERSITÉ DE STRASBOURGInventors: Fouzia Boulmedais, Delphine Chan-Seng, Nicolas Zydziak, Philippe Lavalle
-
Patent number: 9464100Abstract: An organosilicon compound having a hydrolyzable silyl group and a catechol group in the molecule is novel. When modified by surface treatment with an adhesive composition comprising the organosilicon compound, various inorganic materials such as glass and metals become tightly adherent to epoxy and other resins.Type: GrantFiled: October 23, 2015Date of Patent: October 11, 2016Assignee: SHIN-ETSU CHEMICAL CO., LTD.Inventor: Munenao Hirokami
-
Patent number: 8981025Abstract: Disclosed herein are functionalized cationic peptide monomers: peptide chains of two or more positively charged amino acids chosen from lysine or arginine, or derivatives thereof, which are functionalized, meaning that they are bound to one or more polymerization moieties. The functionalized cationic peptide monomers can be described by the formula Z-Xaan-Z1n1 wherein Z and Z1 are polymerization moieties and n1 is an integer of 0 or 1; Xaa is each independently an amino acid Lys or Arg and n is an integer from 2 to 10 and wherein at least one Xaa amino acid of Xaa is Lys, wherein the carboxyl terminus of the amino acid sequence is amidated. Functionalized cationic peptide monomers can be combined and polymerized to form cell culture surfaces.Type: GrantFiled: February 9, 2012Date of Patent: March 17, 2015Assignee: Corning IncorporatedInventors: Dana Craig Bookbinder, Paul Ernest Gagnon, Jr., Arthur Winston Martin, Jodelle Karen Nelson, Shawn Michael O'Malley
-
Publication number: 20140199232Abstract: Disclosure of methods and compositions related to chemical conjugations to nanoparticles of polysaccharides cross-linked to poloxamers as well as nano-sized colloids comprised of polysaccharides and poloxamers. The nanoparticles may be produced by various methods including inverse miniemulsion polymerization processes which create nanogels of desired size, shape, and stability for controlled therapeutic drug delivery, imaging, and theragnostic applications.Type: ApplicationFiled: July 16, 2013Publication date: July 17, 2014Applicant: NANODERM SCIENCES, INC.Inventors: Richard A. Winchurch, Roy R. Yeoman
-
Publication number: 20140155313Abstract: The present invention provides methods of synthesizing hydrogels that contain covalently linked polypeptides. These polypeptides may be tetravalent peptides or polypeptides that bind to cell surface receptors. The hydrogels synthesized by the methods of the present invention may be used in wound dressings or applied directly to wounds to promote healing.Type: ApplicationFiled: December 4, 2013Publication date: June 5, 2014Applicant: SUSAVION BIOSCIENCES, INC.Inventors: Laura L. Eggink, J. Kenneth Hoober
-
Publication number: 20130281602Abstract: A thermo-responsive polymer covalently bound with a peptide, wherein the peptide comprises a peptide moiety that is able to self-assemble and a functional peptide moiety comprising a bioactive sequence, and compositions comprising such thermo-responsive polymer covalently bound with a peptide. Methods for the preparation of such thermo-responsive polymers covalently bound with a peptide and the use thereof for the preparation of hydrogels.Type: ApplicationFiled: October 6, 2011Publication date: October 24, 2013Applicant: SOLVAY SAInventors: Alberto Saiani, Aline Miller, Roland Callens, Laurent Jeannin, Wafa Moussa
-
Patent number: 8481678Abstract: Peptide-based reagents comprising at least one tooth surface-binding peptide for delivery of at least one polymer-coated white colorant to the surface of teeth are provided. The peptide-based reagent may comprise at least one tooth-binding peptide coupled to, either directly or through one or more spacers, a polymer-binding peptide capable of binding to the polymeric coating on a polymer-coated white colorant. Methods of delivering a polymer-coated white colorant to a tooth surface are also provided as well as oral care compositions comprising the present peptide-based reagents. The peptide-based reagents may be used in conjunction with at least one polymer-coated white colorant to improve the cosmetic appearance of teeth.Type: GrantFiled: February 2, 2010Date of Patent: July 9, 2013Assignee: E I du Pont de Nemours and CompanyInventors: Douglas Robert Anton, Scott D. Cunningham, Stephen R. Fahnestock, Kari A. Fosser, Hong Wang
-
Patent number: 8344082Abstract: The present invention relates to new molecularly imprinted polymers which are suitable for the selective recognition of glutathione GSH and/or of an analog thereof, and in particular which are of use for the treatment of media comprising in particular a mixture of glutathione GSH, and/or of an analog thereof, with GSH adducts.Type: GrantFiled: October 8, 2008Date of Patent: January 1, 2013Assignee: PolyintellInventors: Celine Perollier, Sami Bayoudh
-
Publication number: 20120208972Abstract: Disclosed herein are functionalized cationic peptide monomers: peptide chains of two or more positively charged amino acids chosen from lysine or arginine, or derivatives thereof, which are functionalized, meaning that they are bound to one or more polymerization moieties. The functionalized cationic peptide monomers can be described by the formula Z-Xaan-Z1n1 wherein Z and Z1 are polymerization moieties and n1 is an integer of 0 or 1; Xaa is each independently an amino acid Lys or Arg and n is an integer from 2 to 10 and wherein at least one Xaa amino acid of Xaa is Lys, wherein the carboxyl terminus of the amino acid sequence is amidated. Functionalized cationic peptide monomers can be combined and polymerized to form cell culture surfaces.Type: ApplicationFiled: February 9, 2012Publication date: August 16, 2012Inventors: Dana Craig Bookbinder, Paul Ernest Gagnon, JR., Arthur Winston Martin, Jodelle Karen Nelson, Shawn Michael O'Malley
-
Patent number: 8232360Abstract: The invention relates to stereoregular ROMP polymers, the monomers used to make them, and the processes used to convert the monomers to the polymers.Type: GrantFiled: July 17, 2007Date of Patent: July 31, 2012Assignee: Research Foundation of State University of N.Y.Inventors: Nicole S. Sampson, Kathlyn A. Parker
-
Publication number: 20120082728Abstract: The present invention relates to the field of drug delivery nanosystems. More precisely, the present invention concerns a copolymer with advantageous properties for the outer coating of various nanoparticles. Said copolymer comprises at least three types of monomers with stealthy, coupling and therapeutic properties respectively, as well as an optional fourth type of monomers with targeting properties. The present invention also relates to core-shell or hollow shell nanoparticles coated by an external layer of the copolymer according to the invention. Several types of core-shell nanoparticles are envisaged. The invention also concerns methods for preparing said nanoparticles, as well as pharmaceutical compositions or medicaments comprising them.Type: ApplicationFiled: January 21, 2010Publication date: April 5, 2012Applicant: UNIVERSITE DE STRASBOURGInventors: Grégory F. Schneider, Gero Decher, Karel Ulbrich, Vladimir Subr
-
Patent number: 8133504Abstract: This invention related to a tissue-adhesive sheet comprising a homogeneous, preformed and cross-linked matrix formed from one or more polymers, and having at least one surface that, in use, is exposed, at least one of said one or more polymers being a synthetic polymer and having appendant functional groups of a first form, cross-linking of said matrix being via a proportion of said functional groups of the first form, and the remainder of said functional groups of the first form being free. The sheet is particularly useful as a tissue adhesive and sealant, and is intended for topical application to internal and external surfaces of the body for therapeutic reasons. The invention further relates to sheets comprising a scaffold material, three-dimensional articles formed from similar material to that of the sheet and to implantable medical devices coated with such material.Type: GrantFiled: July 29, 2005Date of Patent: March 13, 2012Assignee: Tissuemed LimitedInventors: Graeme Kettlewell, David John Mandley, David Harry Fortune, Ian Thompson, Diane Morris
-
Publication number: 20120014904Abstract: The site-specific expression of selectins on endothelial cells of blood vessels during angiogenesis provides an opportunity to target anti-cancer drugs to the vascular endothelium to extend the range of the therapeutic effect. This invention describes an innovative drug targeting strategy for the selective delivery of the anticancer drugs to endothelial cells by means of polymer-drug conjugates modified with a carbohydrate ligand for the vascular selectins. A model chemotherapeutic drug, doxorubicin, and the E-selectin ligand, sLex, are attached to a biocompatible polymer (HPMA). The selective binding, cellular uptake, intracellular fate, and cell cytotoxicity of the polymer-bound drug are investigated in human endothelial cells.Type: ApplicationFiled: November 24, 2010Publication date: January 19, 2012Inventors: Ayelet DAVID, Gonen Ashkenszy, Yosi Shamay
-
Publication number: 20110319569Abstract: The invention generally relates to zwitterionic polymers (including zwitterionic copolymers), such as polymethacrylic structures, with pendent functional moieties, such as therapeutic or biologic moieties. More particularly, the invention relates to phosphorylcholine-substituted methacrylic polymers prepared by free radical polymerization and click chemistry, for example, and compositions and products comprising same, as well as related methods and uses of the compositions, for example, as biological or therapeutic agents and in drug delivery thereof.Type: ApplicationFiled: December 11, 2009Publication date: December 29, 2011Applicant: University of MassachusettsInventors: Todd Emrick, Xiangji Chen, Samantha McRae
-
Publication number: 20110288252Abstract: The present invention relates to silanes with the formula (I) RaQbSiX4-a-b (I) wherein the radicals and indices have the following meaning: R is optionally the same or different and identifies a straight-chain, branched-chain and/or cyclic alkyl, alkenyl, aryl, alkylaryl or arylalkyl group or a straight-chain or branched and/or cyclic organic radical with at least one organically polymerizable group, wherein the carbon chains can each be interrupted by one or more oxygen or sulfur atoms or carboxyl or carbonamide or amino groups or can hold one or more groups selected from carboxylic acid groups, carbonamide groups, amino groups, hydroxy groups and mercapto groups, at one of the ends of said carbon chains, Q is (C6H3)(OR1)2 or R3(C6H3)(OR1)2, where R1 indicates hydrogen or a C1C4- alkyl group, and R3 is a substituted or unsubstituted carbon chain that is interrupted by either one or by multiple groups selected from —O—, —NH—, —NHC(O)—, —C(O)NH—, —C(O)NHC(O)—, —NHC(O)NH—, —C(O)O—, —NHC(O)O—, —C(O)—, —OC(O)NHC(Type: ApplicationFiled: November 16, 2009Publication date: November 24, 2011Inventors: Thomas Ballweg, Somchith Nique
-
Publication number: 20110251363Abstract: The invention relates to stereoregular ROMP polymers, the monomers used to make them, and the processes used to convert the monomers to the polymers.Type: ApplicationFiled: July 17, 2007Publication date: October 13, 2011Inventors: Nicole S. Sampson, Kathlyn A. Parker
-
Patent number: 8022155Abstract: The invention relates to polymerizable compositions which comprise 10-80% by weight of a reactive diluent based on acrylic acid or methacrylic acid derivatives, and 10-50% by weight of a monomer of the indicated chemical formula which is liquid or which can be dissolved in the formulation. The formula may contain amino acid residues or peptide sequences, especially such that are specific of the collagen. These structural elements allow the enzymatic degradation of the polymers of the inventive composition.Type: GrantFiled: April 10, 2006Date of Patent: September 20, 2011Assignee: Technische Universitat WienInventors: Robert Liska, Monika Schuster, Jürgen Stampfl, Heinrich Gruber, Franz Varga
-
Publication number: 20110183418Abstract: Functionalized peptide monomers, peptides that have been functionalized to contain a polymerization moiety, are disclosed. The use of these functionalized peptide monomers to form peptide polymers which are useful as synthetic surfaces capable of supporting culture of cells in culture, particularly cells that will be used therapeutically, is also disclosed. Methods of making the surfaces and methods of using the surfaces are also disclosed.Type: ApplicationFiled: July 28, 2010Publication date: July 28, 2011Inventors: Arthur Winston Martin, Jodelle Karen Nelson, Christopher Bankole Shogbon, David Michael Weber, Yue Zhou
-
Publication number: 20100247457Abstract: Peptide-based reagents comprising at least one tooth surface-binding peptide for delivery of at least one polymer-coated white colorant to the surface of teeth are provided. The peptide-based reagent may comprise at least one tooth-binding peptide coupled to, either directly or through one or more spacers, a polymer-binding peptide capable of binding to the polymeric coating on a polymer-coated white colorant. Methods of delivering a polymer-coated white colorant to a tooth surface are also provided as well as oral care compositions comprising the present peptide-based reagents. The peptide-based reagents may be used in conjunction with at least one polymer-coated white colorant to improve the cosmetic appearance of teeth.Type: ApplicationFiled: February 2, 2010Publication date: September 30, 2010Applicant: E. I. DU PONT DE NEMOURS AND COMPANYInventors: DOUGLAS ROBERT ANTON, Scott D. Cunningham, Stephen R. Fahnestock, Kari A. Fosser, Hong Wang
-
Publication number: 20100234565Abstract: The present invention relates to new molecularly imprinted polymers which are suitable for the selective recognition of glutathione GSH and/or of an analog thereof, and in particular which are of use for the treatment of media comprising in particular a mixture of glutathione GSH, and/or of an analog thereof, with GSH adducts.Type: ApplicationFiled: October 8, 2008Publication date: September 16, 2010Applicant: POLYINTELLInventors: Celine Perollier, Sami Bayoudh
-
Publication number: 20100150952Abstract: pH-Responsive polymer-based protein delivery carriers and compositions, methods for making the carriers and compositions, and methods for using the carriers and compositions for intracellular protein antigen delivery, inducing a cytotoxic T-lymphocyte response, introducing a tumor-specific protein antigen to an antigen presenting cell to induce an immune response, and providing tumor protection to a subject.Type: ApplicationFiled: November 9, 2009Publication date: June 17, 2010Applicant: UNIVERSITY OF WASHINGTONInventors: Patrick S. Stayton, Suzanne Foster, Allan S. Hoffman
-
Publication number: 20100099786Abstract: The invention relates to a compound comprising (a) at least two polymerisable moieties, (b) at least one amino acid residue of an amino acid comprising at least two amine groups of which at least two amine groups have formed a carbamate, a thiocarbamate or a carbamide group, and (c) a biomolecular moiety linked directly or via a spacer to the carboxylic acid moiety of the diamino acid residue or a carboxylic acid to which such moiety can be linked. The invention further relates to a polymer obtainable from such compound.Type: ApplicationFiled: November 7, 2007Publication date: April 22, 2010Inventors: Aylvin Jorge Angelo Athanasius Dias, Bartholomeus Johannes Margretha Plum, Peter Jan Leonard Mario Quaedflieg, Roel Wim Wiertz
-
Publication number: 20090227750Abstract: The present invention provides a method for enhancing an immune response in a mammal to facilitate the elimination of a chronic pathology. The method involves the removal of immune system inhibitors such as soluble TNF receptor from the circulation of the mammal, thus, enabling a more vigorous immune response to the pathogenic agent. The removal of immune system inhibitors is accomplished by contacting biological fluids of a mammal with one or more binding partner(s) such as TNF? muteins capable of binding to and, thus, depleting the targeted immune system inhibitor(s) from the biological fluids. Particularly useful in the invention is an absorbent matrix composed of an inert, biocompatible substrate joined covalently to a binding partner, such as a TNF? mutein, capable of specifically binding to a targeted immune system inhibitor such as soluble TNF receptor.Type: ApplicationFiled: February 11, 2009Publication date: September 10, 2009Inventor: Mark Douglas Howell
-
Patent number: 6977285Abstract: Functional polyvalent oligomer for applications in medicine and biotechnology are disclosed. These oligomers have the formula (1) wherein R is H, CH3, C2H5, R1, is H, NH2, OH, COOH, X is N-Acetyl Glucosamine, mannose, galactose and sialic acid, fructose, ribulose, erythrolose, xylulose, psicose, sorbose, tagatose, glucopyranose, fructofuranose, deoxyribose, galactosamine, sucrose, lactose, isomaltose, maltose, cellobiose, cellulose and amylose, Y is H, COOH, OH or NH2, and n is from 3 to 50. The present invention also relates to synthesis of such oligomeric ligands. The method of synthesis of the present invention for oligomerization can be—applied to other ligands such as sialic acid, mannose and galactose and can -be used for the prevention of infections.Type: GrantFiled: March 30, 2004Date of Patent: December 20, 2005Assignee: Council of Scientific and Industrial ResearchInventors: Mohan Gopalkrishna Kulkarni, Jayant Jagannath Khandare
-
Patent number: 6884842Abstract: Synthetic polymer complements (SPCs) are provided, as well as methods for their synthesis and use. The SPCs may have surfaces that include functional groups that are complementary to surface sites of targets such as nanostructures or macromolecular targets, and may be capable of specifically interacting with such targets. The positions of the functional groups in one embodiment are stabilized by a polymer network. The SPCs are formed by contacting the target with a set of monomers which self-assemble on the target, and then are polymerized into a network to form the synthetic polymer complement. At least a portion of the surface of the resulting SPC thus may include an imprint of the target. The complex of the SPC and the target may be the desired product. Alternatively, the target is released, for example, by controllably expanding and contracting the crosslinked network. The SPC is isolated and used in many applications.Type: GrantFiled: October 26, 2001Date of Patent: April 26, 2005Assignee: Alnis BioSciences, Inc.Inventors: David S. Soane, Stephen E. Barry, Andrew Goodwin, David A. Offord, Michael G. Perrott
-
Publication number: 20040072976Abstract: The development of low dielectric constant materials from renewable resources such as plant oils and feathers is described in this invention. Soybean resin such as but not limited to, acrylated epoxidized soybean oil (AESO) and soybean oil pentaerythritol glyceride maleates (SOPERMA) is mixed with a reactive diluent such as but not limited to, styrene monomer. After that, various concentrations of chicken feather fibers or the fiber mats are mixed with the resin physically or using various process techniques such as resin transfer molding (RTM) and vacuum assisted resin transfer molding (VARTM) process. The mixtures are then free radically copolymerized at various temperatures to produce rigid composites. Surprisingly, the dielectric constants of the chicken feather composites are sufficiently low for electronic applications and lower than that of conventional semiconductor material such as silicon dioxide.Type: ApplicationFiled: July 17, 2003Publication date: April 15, 2004Applicant: UNIVERSITY OF DELAWAREInventors: Richard P. Wool, Chang K. Hong
-
Patent number: 6709734Abstract: Disclosed are a resin sheet that has a resin layer which is made up of a thermoplastic resin and which has a degree of orientation of not less than 0.0002 and not more than 0.0020, and a thermoformed article and laminate structure. The resin sheet is preferably employed in a thermoforming process. Particlarly favorable application of the resin sheet is a paintless film, which is usually thermoformed and then laminated to a molten resin.Type: GrantFiled: August 20, 2002Date of Patent: March 23, 2004Assignee: Sumitomo Chemical Company, LimitedInventors: Kenichi Higashi, Kouichi Yanase
-
Patent number: 6548601Abstract: An ambient oxidative cure composition based on an acrylate functionalized alkyd resin is described. A method of preparing an ambient oxidative cure composition based on an acrylate functionalized alkyd resin is also described. Such ambient oxidative cure compositions may be used in, for example, fast drying, high solid paint or enamel compositions or formulations.Type: GrantFiled: June 16, 2000Date of Patent: April 15, 2003Assignee: Eastman Chemical CompanyInventors: Thauming Kuo, Mark D. Clark
-
Patent number: 6525154Abstract: Molecularly imprinted polymers (MIPs) wherein the template comprises either a) a peptide or amino acid sequence that has an N-terminal histidine residue or b) histamine. The MIP's may be prepared in aqueous systems using reagents that are water soluble at the relevant concentrations. Also, the invention includes methods for using the MIP's as receptors or adsorbents for, or to determine the present or non-presence of, target molecules containing i) particular peptides or amino acid sequences having N-terminal histidine residue or ii) histamine.Type: GrantFiled: July 20, 2001Date of Patent: February 25, 2003Assignee: The Regents of the University of CaliforniaInventors: Kenneth J. Shea, Bradley R. Hart
-
Patent number: 6489418Abstract: This patent application describes the use of molecular imprinting as a means for preparation of anti-idiotypic imprint matrices. With this technique, imprints of artificial or natural molecules including their recognition sites, such as of molecularly imprinted polymers or biological receptors, antibodies or enzymes, can be prepared. In the former case, using the original imprints as casts or molds in a subsequent polymerisation step, utilising preferentially functionally complementary monomers, the formation of imprint materials containing recognition sites complementary in shape and functionality with the original imprint can be obtained but being of different composition. Alternatively, imprints or images of the artificial or biological species can be obtained directly. The so formed preparations can be used in a vast variety of applications, e.g. as new drugs, inhibitors or new affinity materials.Type: GrantFiled: April 2, 1996Date of Patent: December 3, 2002Inventor: Klaus Mosbach
-
Publication number: 20020169264Abstract: The present invention provides polymers incorporating peptides. The polymers comprise polymarised units of (1) CH2═CR4—CO—X—R1 and (2) CH2═CR3—CO—R2 and optionally one or more other monomers, in which R1 is a peptide. Each R1 may be the same, or is preferably different. In another embodiment the present invention provides polymers formed from CH2═CR4—CO—X—R1 and optionally one or more other monomers, in which X is a spacer having a length equivalent to 1 to 30 single C—C bonds and R1 is a peptide, each R1 being the same or different. The invention further relates to methods producing the polymers and methods of inducing an immune response using the polmers.Type: ApplicationFiled: January 11, 2002Publication date: November 14, 2002Applicant: The Council of the Queensland Institute of Medical ResearchInventors: David C. Jackson, Neil M. O'Brien-Simpson, Lorena E. Brown, Nicholas J. Ede, Evelyn R. Brandt, Michael F. Good, Weiguang Zeng
-
Patent number: 6372813Abstract: The present invention provides solid supports (e.g., glass) and polymer hydrogels (particularly polymer hydrogel arrays present on a solid support) comprising one or more reactive sites for the attachment of biomolecules, as well as biomolecules comprising one or more reactive sites for attachment to solid supports and polymer hydrogels. The invention further provides novel compositions and methods for the preparation of biomolecules, solid supports, and polymer hydrogels comprising reactive sites. The invention also provides for preparation of crosslinked solid supports, polymer hydrogels, and hydrogel arrays, wherein one or more biomolecules is attached by means of the reactive sites in a photocycloaddition reaction. Advantageously, according to the invention, crosslinking of the hydrogel and attachment of biomolecules can be done in a single step.Type: GrantFiled: June 25, 1999Date of Patent: April 16, 2002Assignee: MotorolaInventors: Travis Johnson, John McGowen, Allyson Beuhler, Charles Kimball Brush, Robert Emil Lajos
-
Patent number: 6291616Abstract: Methods of preparing a telechelic polymer (mono- or bi-telechelic) that use a ruthenium or osmium carbene catalyst and a capping agent, at least one of which is functionalized.Type: GrantFiled: June 17, 1999Date of Patent: September 18, 2001Assignee: Wisconsin Alumni Research FoundationInventors: Laura L. Kiessling, Eva J. Gordon, Laura E. Strong